Delivery Order SPE2DR25D3014-SPE2DR26FP1JV
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,551.70 by the Defense Logistics Agency on December 9, 2025, for the supply of Qualiptá 60 mg tablets in a quantity of 30 units. This firm fixed price delivery order, with an ultimate completion date of December 10, 2025, represents a non-competitive set-aside contract and will be performed at the vendor's Conshohocken facility. The award falls...
- The Defense Logistics Agency awarded a delivery order valued at $1,497.83 to AmerisourceBergen Drug Corp on December 2, 2025, under the Pharmaceutical Prime Vendor Division contract. This firm fixed-price delivery order, which has a completion date of December 3, 2025, represents a child contract action under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $146,938.40 by the Defense Logistics Agency's Medical Supply Chain on November 5, 2025, with an ultimate completion date of November 6, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $20,168.26 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends...
- The Defense Logistics Agency awarded a $16,035.05 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Qualipita 60 mg tablets (30-count packages). This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The pharmaceutical will be supplied from the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp on December 17, 2025, under a Firm Fixed Price contract type. The award, issued under the Pharmaceutical PV Division, represents a child order placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00 through December 2026. This prime contract vehicle enables AmerisourceBergen to...
- The Defense Logistics Agency awarded a delivery order valued at $1,873.41 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on November 14, 2025, with a completion date of November 17, 2025. This firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through...
- The Defense Logistics Agency awarded a delivery order valued at $1,202.75 to AmerisourceBergen Drug Corp on December 2, 2025, with completion expected by December 3, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order falls under the Pharmaceutical Prime Vendor...
- The Defense Logistics Agency awarded a $1,599.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 4, 2025, with completion scheduled for December 5, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was made on a competitive, non-set-aside basis to the major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $4,939.34 to AmerisourceBergen Drug Corp on December 11, 2025, under the Pharmaceutical PV (Prime Vendor) Division program. This firm fixed-price delivery order, with an ultimate completion date of December 12, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through competitive procedures with no set-aside designation, and...
- SPE2DR25D3014Indefinite Delivery Contract
- SPE2DR25D3014-SPE2DR26FP1JVDelivery Order
The Defense Logistics Agency awarded a $2,242.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Qualipita 60 mg tablets (30-count). AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and reflects the company's capability to meet federal pharmaceutical supply requirements across multiple therapeutic domains. The delivery order is scheduled for completion by December 18, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This contract exemplifies the Defense Logistics Agency's reliance on established pharmaceutical prime vendors to supply specialized medications supporting military healthcare operations. AmerisourceBergen's comprehensive IDC vehicle enables the agency to efficiently procure a diverse range of pharmaceutical products and medical supplies on a global basis, supporting the Defense Health Agency and other federal healthcare systems. The Pharmaceutical Prime Vendor Global Program represents a strategic approach to pharmaceutical procurement, with the Defense Logistics Agency planning to establish Generation V contracts with multiple regional awards to maintain supply chain resilience and competitive pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 12/16/25 |